Skip to content

Evaluating the effect of simultaneous use of persica and chlorhexidine on chemotherapy-induced oral ulcers of children between 6 and 12 year old

The comparison of the effect of chlorhexidine and combination of cholorhexidine-persica mouthwashes on chemotherapy-induced mucositis of children with hematologic malignancies

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014060117935N1
Enrollment
40
Registered
2014-07-15
Start date
2014-06-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy-induced mucositis. Other and unspecified lesions of oral mucosa

Interventions

Intervention 1: Rinsing with normal saline (15 ml) followed by chlorhexidine 0.2% mouthwash (15 ml), 2 times a day (after breakfast and dinner) for 2 weeks. Intervention 2: Rinsing with persica oral d
Prevention
Rinsing with normal saline (15 ml) followed by chlorhexidine 0.2% mouthwash (15 ml), 2 times a day (after breakfast and dinner) for 2 weeks
Rinsing with persica oral drops (10 drops in 15 ml water) followed by chlorhexidine 0.2% mouthwash (15 ml), twice a day (after breakfast and dinner) for 2 weeks

Sponsors

Vice Chancellor for Research of Shahid Sadoughi University of Medical Sciences of Yazd
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age range of 6-12 years; history of hematologic malignancies with the same treatment protocol; no history of sensitivity to any substances; no history of asthma, allergic rhinitis and dermatitis; no need of radiotherapy; written informed consent obtained from parents or legal guardian. Exclusion criteria: occurrence of any infection; occurrence of sensitivity to mouth-rinses.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Incidence of mucositis. Timepoint: Day 1 (before intervention), 8 and 15. Method of measurement: World Health Organization (WHO) grading.;Severity of mucositis. Timepoint: Day 1 (before intervention), 8 and 15. Method of measurement: World Health Organization (WHO) grading; Oral Assessment Guide (OAG) grading.

Secondary

MeasureTime frame
Severity of pain. Timepoint: Day 1 (before intervention), 8 and 15. Method of measurement: Facial Image Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Yasamin Khaksar

Dental Faculty of Shahid Sadoughi University of Medical Sciences of Yazd

yasamin.khaksar@gmail.com+98 35 1625 5881

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026